Keurig Dr Pepper, Inc (NASDAQ:KDP) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Consensus "Hold": Sixteen analysts rate Keurig Dr Pepper a consensus Hold (1 sell, 7 hold, 8 buy) with an average 1‑year price target of $34.36, although some firms recently raised targets to $38–$40 while others cut theirs to $28.
• Operationally KDP modestly beat the quarter (EPS $0.60 vs. $0.59; revenue $4.50B vs. $4.35B), set FY2026 guidance of $2.130–2.170 EPS versus ~1.92 Street expectations, and currently trades around $25.31 (52‑week range $25.03–$36.12) with a PE of about 16.5.
• Shareholder returns and ownership: the company declared a $0.23 quarterly dividend (annualized $0.92) for a yield of 3.6% (ex‑dividend Mar 27, pay Apr 10), and institutional investors own roughly 93.99% of the stock with sizable recent buys by Vanguard, Wellington and T. Rowe Price.

Shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Get Free Report) have earned a consensus recommendation of "Hold" from the sixteen research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $34.3571.

A number of equities analysts recently weighed in on the company. Piper Sandler boosted their target price on Keurig Dr Pepper from $35.00 to $38.00 and gave the stock an "overweight" rating in a research report on Monday, December 15th. Wells Fargo & Company increased their price target on shares of Keurig Dr Pepper from $35.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, February 25th. UBS Group reissued a "buy" rating and set a $36.00 price target on shares of Keurig Dr Pepper in a research note on Thursday, February 26th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Keurig Dr Pepper from $34.00 to $28.00 and set a "hold" rating for the company in a report on Monday, March 30th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Keurig Dr Pepper in a research note on Wednesday, January 28th.

Keurig Dr Pepper Price Performance

KDP opened at $25.31 on Friday. The business's fifty day simple moving average is $28.02 and its 200 day simple moving average is $27.60. Keurig Dr Pepper has a 52 week low of $25.03 and a 52 week high of $36.12. The company has a quick ratio of 0.43, a current ratio of 0.64 and a debt-to-equity ratio of 0.51. The stock has a market cap of $34.39 billion, a PE ratio of 16.54, a P/E/G ratio of 1.28 and a beta of 0.35.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.01. Keurig Dr Pepper had a return on equity of 11.14% and a net margin of 12.52%.The firm had revenue of $4.50 billion during the quarter, compared to analyst estimates of $4.35 billion. During the same quarter in the previous year, the company posted $0.58 earnings per share. The company's revenue was up 10.6% compared to the same quarter last year. Keurig Dr Pepper has set its FY 2026 guidance at 2.130-2.170 EPS. As a group, research analysts expect that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 27th will be issued a dividend of $0.23 per share. The ex-dividend date is Friday, March 27th. This represents a $0.92 annualized dividend and a yield of 3.6%. Keurig Dr Pepper's dividend payout ratio is currently 60.13%.

Institutional Trading of Keurig Dr Pepper

Several hedge funds and other institutional investors have recently bought and sold shares of KDP. Vanguard Group Inc. increased its stake in shares of Keurig Dr Pepper by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 160,958,816 shares of the company's stock worth $4,508,456,000 after buying an additional 1,538,456 shares during the period. State Street Corp boosted its position in Keurig Dr Pepper by 1.6% during the 3rd quarter. State Street Corp now owns 64,594,706 shares of the company's stock valued at $1,662,361,000 after buying an additional 986,700 shares during the period. Wellington Management Group LLP boosted its position in Keurig Dr Pepper by 37.0% during the 4th quarter. Wellington Management Group LLP now owns 57,003,344 shares of the company's stock valued at $1,596,664,000 after buying an additional 15,393,753 shares during the period. Geode Capital Management LLC grew its holdings in Keurig Dr Pepper by 3.9% in the 4th quarter. Geode Capital Management LLC now owns 31,802,056 shares of the company's stock worth $887,021,000 after acquiring an additional 1,187,457 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. bought a new stake in Keurig Dr Pepper in the 4th quarter worth $727,667,000. Institutional investors own 93.99% of the company's stock.

About Keurig Dr Pepper

Keurig Dr Pepper NASDAQ: KDP is a North American beverage company formed in July 2018 through the combination of Keurig Green Mountain and Dr Pepper Snapple Group. The company designs, manufactures, markets and distributes a wide range of hot and cold beverages and related equipment, combining Keurig's single‑serve coffee systems with a large portfolio of carbonated and noncarbonated drink brands. It operates a network of manufacturing, packaging and distribution facilities to supply retail, foodservice and e-commerce channels across its served markets.

The company's product mix includes single‑serve coffee brewers and coffee pods under the Keurig brand as well as a broad assortment of branded beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.